The National Cancer Institute is offering Exploratory Grants in Cancer Control (R21) to support novel scientific ideas and the early conceptual stages of research aimed at substantially advancing population-based cancer research. This grant is specifically for projects focused on key aspects of cancer control, including modifying behaviors, enhancing screening strategies, understanding etiologic factors contributing to cancer development, and devising new control methodologies. Successful proposals will introduce novel techniques, agents, methodologies, models, or applications that promise a major impact across diverse fields such as epidemiologic, biomedical, behavioral, health care delivery, or clinical cancer research. The overarching purpose is to foster innovative efforts that can significantly improve cancer control.
Opportunity ID: 336094
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-341 |
| Funding Opportunity Title: | Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Oct 12, 2021 |
| Last Updated Date: | Oct 12, 2021 |
| Original Closing Date for Applications: | Oct 08, 2024 |
| Current Closing Date for Applications: | Oct 08, 2024 |
| Archive Date: | Nov 13, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses Public and State controlled institutions of higher education County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Independent school districts Native American tribal governments (Federally recognized) Special district governments State governments Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses City or township governments Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (epidemiologic, biomedical, behavioral, health care delivery or clinical). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-341.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 336094 Full Announcement-PAR-21-341 -> PAR-21-341-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00270320 | May 07, 2022 | Jan 24, 2023 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00269275 | May 07, 2022 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278137 | Nov 08, 2022 | Oct 08, 2024 | View |
Package 1
Mandatory forms
336094 RR_SF424_5_0-5.0.pdf
336094 PHS398_CoverPageSupplement_5_0-5.0.pdf
336094 RR_OtherProjectInfo_1_4-1.4.pdf
336094 PerformanceSite_4_0-4.0.pdf
336094 RR_KeyPersonExpanded_4_0-4.0.pdf
336094 PHS398_ResearchPlan_4_0-4.0.pdf
336094 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
336094 RR_Budget_3_0-3.0.pdf
336094 RR_SubawardBudget30_3_0-3.0.pdf
336094 PHS398_ModularBudget_1_2-1.2.pdf
336094 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
336094 RR_SF424_2_0-2.0.pdf
336094 PHS398_CoverPageSupplement_5_0-5.0.pdf
336094 RR_OtherProjectInfo_1_4-1.4.pdf
336094 PerformanceSite_2_0-2.0.pdf
336094 RR_KeyPersonExpanded_2_0-2.0.pdf
336094 PHS398_ResearchPlan_4_0-4.0.pdf
336094 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
336094 RR_Budget_1_4-1.4.pdf
336094 RR_SubawardBudget30_1_4-1.4.pdf
336094 PHS398_ModularBudget_1_2-1.2.pdf
336094 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
336094 RR_SF424_5_0-5.0.pdf
336094 PHS398_CoverPageSupplement_5_0-5.0.pdf
336094 RR_OtherProjectInfo_1_4-1.4.pdf
336094 PerformanceSite_4_0-4.0.pdf
336094 RR_KeyPersonExpanded_4_0-4.0.pdf
336094 PHS398_ResearchPlan_5_0-5.0.pdf
336094 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
336094 RR_Budget_3_0-3.0.pdf
336094 RR_SubawardBudget30_3_0-3.0.pdf
336094 PHS398_ModularBudget_1_2-1.2.pdf
336094 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
